
DarioHealth (DRIO) Stock Forecast & Price Target
DarioHealth (DRIO) Analyst Ratings
Bulls say
DarioHealth is a leading digital therapeutics company, utilizing proprietary data, devices, and AI to provide personalized interventions and coaching for chronic conditions. With strong gross margins and a growing contracted ARR, the company is well-positioned for sustained growth and eventual profitability. However, there are potential risks associated with government-driven HCIT spending and competition in the industry.
Bears say
DarioHealth is a digitally focused company with a vertically integrated health intelligence platform and a potential for expansion through cross-selling to legacy customers. While their recent expansion with a national health plan and a Fortune 50 company show promising commercial progress, there are potential risks associated with the HCIT space that could slow growth and impact profitability. With a focus on cost management, DarioHealth may have improved its financials, but a challenging digital health demand environment and limited growth visibility in certain channels may present challenges for the company's future success.
This aggregate rating is based on analysts' research of DarioHealth and is not a guaranteed prediction by Public.com or investment advice.
DarioHealth (DRIO) Analyst Forecast & Price Prediction
Start investing in DarioHealth (DRIO)
Order type
Buy in
Order amount
Est. shares
0 shares